https://www.etnownews.com/companies/usd-5-5-billion-deal-biocon-to-merge-biologics-unit-to-acquire-stake-held-by-serum-mylan-article-153261162
Dec 8, 2025 - USD 5.5 billion deal: Biocon plans to buy the remaining shares of its subsidiary, Biocon Biologics Limited, by exchanging its own shares. This deal values...
usdbilliondealbioconmerge
https://cfo.financialexpressb2b.com/interviews/currency-volatility-is-now-a-routine-occurrence-kedar-upadhye-cfo-biocon-biologics
The finance leader discusses navigating currency volatility while driving growth through new product launches and balance sheet simplification.
currencyvolatilityroutineoccurrencekedar
https://www.business-standard.com/amp/companies/news/biocon-biologics-yesintek-us-market-access-approval-125050500182_1.html
Biocon Biologics' biosimilar Yesintek is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, and...
biocon biologicsmarket accessmultiplecoverageyesintek
https://www.financialexpress.com/market/biocon-merger-with-biocon-biologics-what-does-the-5-5-billion-valuation-mean-for-investors-4069252/?ref=hometop_hp
Biocon merges with Biocon Biologics in a $5.5B deal; find out how this impacts investors and share prices today!
what doesbioconmergerbiologics